RenovoRx, Inc.
RNXT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $30,452 | $47,131 | $42,543 | $86,481 |
| - Cash | $7,154 | $1,173 | $6,440 | $15,192 |
| + Debt | $278 | $0 | $0 | $0 |
| Enterprise Value | $23,576 | $45,958 | $36,103 | $71,289 |
| Revenue | $43 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $43 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$10,970 | -$11,390 | -$9,944 | -$5,481 |
| % Margin | -25,511.6% | – | – | – |
| Net Income | -$8,814 | -$10,232 | -$9,889 | -$6,324 |
| % Margin | -20,497.7% | – | – | – |
| EPS Diluted | -0.37 | -0.5 | -0.54 | -0.4 |
| % Growth | 26% | 7.4% | -35% | – |
| Operating Cash Flow | -$9,125 | -$10,258 | -$8,811 | -$5,916 |
| Capital Expenditures | -$12 | $0 | $0 | -$15 |
| Free Cash Flow | -$9,137 | -$10,258 | -$8,811 | -$5,931 |